Alpine Global Management’s iTeos Therapeutics ITOS Stock Holding History

Alpine Global Management’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-225,000	Closed	-$2.24M	–	261
2025 Q2	$2.24M	Buy	+225,000	New	+$1.81M	0.51%	34

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Alpine Global Management's ITOS Position: Q3 2025 in Review

Alpine Global Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 225,000 shares — an estimated $2.24M sold.

Alpine Global Management first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $2.24M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Alpine Global Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Alpine Global Management sold 225,000 iTeos Therapeutics shares in Q3 2025, an estimated $2.24M.
Alpine Global Management first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
Alpine Global Management's iTeos Therapeutics position peaked at $2.24M in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Alpine Global Management's 13F filing for Q3 2025, filed 14 Nov 2025.